INEFFECTIVENESS OF CA2+-ANTAGONISTS NICARDIPINE AND DILTIAZEM ON EXPERIMENTAL ATHEROSCLEROSIS IN CHOLESTEROL-FED RABBITS

被引:41
作者
NAITO, M
KUZUYA, F
ASAI, K
SHIBATA, K
YOSHIMINE, N
机构
关键词
D O I
10.1177/000331978403501002
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:622 / 627
页数:6
相关论文
共 8 条
[1]  
FLECKENSTEIN A, 1983, 5TH INT AD S, P36
[2]   SUPPRESSION OF ATHEROGENESIS IN CHOLESTEROL-FED RABBIT TREATED WITH NIFEDIPINE [J].
HENRY, PD ;
BENTLEY, KI .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (05) :1366-1369
[4]   ATHEROSCLEROSIS - PREVENTION BY AGENTS NOT AFFECTING ABNORMAL LEVELS OF BLOOD-LIPIDS [J].
KRAMSCH, DM ;
ASPEN, AJ ;
ROZLER, LJ .
SCIENCE, 1981, 213 (4515) :1511-1512
[5]   SUPPRESSION OF EXPERIMENTAL ATHEROSCLEROSIS BY THE CA++-ANTAGONIST LANTHANUM - POSSIBLE ROLE OF CALCIUM IN ATHEROGENESIS [J].
KRAMSCH, DM ;
ASPEN, AJ ;
APSTEIN, CS .
JOURNAL OF CLINICAL INVESTIGATION, 1980, 65 (05) :967-981
[6]  
NAITO M, 1983, J JAP ATHEROSCLER SO, V11, P997
[7]  
ROBERT A, 1978, AKAD WISS ABH, V63, P301
[8]   PLAQUE REVERSAL WITH MGEDTA IN EXPERIMENTAL ATHEROSCLEROSIS - ELASTIN AND COLLAGEN METABOLISM [J].
WARTMAN, A ;
LAMPE, TL ;
MCCANN, DS ;
BOYLE, AJ .
JOURNAL OF ATHEROSCLEROSIS RESEARCH, 1967, 7 (03) :331-+